Source : Biocon Limited Thursday, June 23, 2016 9:39AM IST (4:09AM GMT)   (BSE:532523)(NSE:BIOCON) Biocon, Quark Announce Initiation of Pivotal Phase II/III Study of QPI-1007 in Rare Eye Disease in India First siRNA...

More